Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
306.4 USD | +2.86% | +4.22% | +8.26% |
Apr. 03 | Icon CFO Brennan to Depart for Outside Opportunity | DJ |
Apr. 03 | Icon Says CFO Brennan Leaving in Q4, Reaffirms Guidance | MT |
Chart calendar ICON Public Limited Company
Upcoming events on ICON Public Limited Company
Past events on ICON Public Limited Company
2024-03-12 02:05 pm | Barclays Global Healthcare Conference |
2024-03-05 11:10 am | TD Cowen Health Care Conference |
2024-02-22 08:00 am | Q4 2023 Earnings Call |
2024-02-21 04:15 pm | Q4 2023 Earnings Release |
2024-01-09 08:15 pm | JPMorgan Healthcare Conference |
2023-12-02 | ASH Meeting |
2023-11-29 12:30 pm | Evercore ISI HealthCONx Conference |
2023-11-20 | OCT DACH Conference |
2023-11-14 | EBF Conference |
2023-11-14 09:00 am | Jefferies London Healthcare Conference |
2023-11-12 | European Site Solutions Summit |
2023-11-11 | ISPOR EU Conference |
2023-10-29 | World Orphan Drug EU Congres |
2023-10-26 08:00 am | Q3 2023 Earnings Call |
2023-10-25 04:15 pm | Q3 2023 Earnings Release |
2023-10-24 | Medical Innovation Forum |
2023-10-23 | OCT Nordics Conference |
2023-10-21 | AAPS PharmSci Conference |
2023-10-15 | WVC EU Conference |
2023-10-05 | Global Site Solutions Summit |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2 806 2 814 -0.29% | 2 797 2 788 0.32% | 5 481 5 494 -0.24% | 7 741 7 744 -0.04% | 8 120 8 146 -0.32% | 8 638 |
EBITDA Million USD | Released Forecast Spread | 495 494 0.18% | 476 471 1.01% | 970 964 0.67% | 1 479 1 463 1.1% | 1 694 1 675 1.16% | 1 840 |
EBIT Million USD | Released Forecast Spread | 433 433 0.15% | 410 403 1.69% | 655 863 -24.1% | 1 373 1 367 0.43% | 1 568 1 562 0.4% | 1 707 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 427 426 0.2% | 381 378 0.84% | 197 399 -50.72% | 568 627 -9.5% | 624 642 -2.69% | 934 |
Net income Million USD | Released Forecast Spread | 374 374 -0.07% | 332 330 0.82% | 153 291 -47.4% | 505 525 -3.68% | 612 557 9.92% | 822 |
EPS USD | Released Forecast Spread | 6,79 6,89 -1.42% | 6,15 6,17 -0.38% | 2,25 3,19 -29.47% | 6,13 6,78 -9.58% | 7,40 6,79 9.04% | 9,67 |
Announcement Date | 19/02/20 | 24/02/21 | 22/02/22 | 22/02/23 | 21/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1 885 1 894 -0.47% | 1 902 1 887 0.8% | 1 935 1 928 0.38% | 1 942 1 934 0.42% | 1 962 1 965 -0.14% | 1 979 1 980 -0.09% | 2 020 2 017 0.15% | 2 055 2 055 0.02% | 2 066 2 093 -1.28% | 2 088 | 2 139 | 2 191 | 2 224 | 2 252 |
EBITDA Million USD | Released Forecast Spread | 333 335 -0.75% | 341 332 2.61% | 354 349 1.54% | 380 371 2.29% | 405 396 2.36% | 399 398 0.39% | 414 412 0.62% | 433 425 1.77% | 448 438 2.24% | 440 | 453 | 467 | 480 | 487 |
EBIT Million USD | Released Forecast Spread | 193 297 -35.14% | 314 306 2.47% | 329 314 4.55% | 353 342 3.09% | 378 370 2.13% | 254 365 -30.45% | 209 383 -45.3% | 401 396 1.4% | 414 409 1.45% | 407 | 418 | 433 | 446 | 448 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 91,8 190 -51.67% | 126 196 -35.71% | 131 184 -28.72% | 182 199 -8.32% | 129 214 -39.78% | 131 147 -10.61% | 125 168 -25.35% | 182 187 -2.59% | 186 214 -12.78% | 207 | 225 | 249 | 274 | 268 |
Net income Million USD | Released Forecast Spread | 76,5 139 -44.87% | 112 165 -32.04% | 116 139 -16.98% | 160 155 3.43% | 117 164 -28.49% | 117 122 -4.23% | 116 162 -28.69% | 164 164 -0.32% | 216 173 25.28% | 169 | 189 | 207 | 229 | 231 |
EPS USD | Released Forecast Spread | 0,92 1,62 -43.21% | 1,36 1,76 -22.87% | 1,41 1,64 -13.95% | 1,94 1,82 6.59% | 1,42 2,15 -33.84% | 1,41 1,45 -2.76% | 1,40 1,67 -16.17% | 1,97 1,98 -0.32% | 2,60 2,11 23.22% | 2,07 | 2,32 | 2,56 | 2,77 | 2,79 |
Announcement Date | 22/02/22 | 27/04/22 | 27/07/22 | 02/11/22 | 22/02/23 | 26/04/23 | 26/07/23 | 25/10/23 | 21/02/24 | - | - | - | - | - |
2024-04-23 | SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release |
2024-04-23 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-23 | CUREVAC N.V.: Q4 2023 Earnings Release |
2024-04-23 | ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release |
2024-04-23 | EVOTEC SE: Q4 2023 Earnings Release |
2024-04-24 01:45 am | ADDLIFE AB: Q1 2024 Earnings Release |
2024-04-24 | PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release |
2024-04-24 | SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release |
2024-04-24 | HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release |
2024-04-24 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Past sector events for ICON Public Limited Company
Today | SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected) |
Today | HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q1 2024 Earnings Release |
Today | HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q4 2023 Earnings Release |
2024-04-22 04:15 pm | MEDPACE HOLDINGS, INC.: Q1 2024 Earnings Release |
2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ICLR Stock
- Calendar ICON Public Limited Company